These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1004685)

  • 1. Ergot alkaloid inhibition of melanophore stimulating hormone secretion.
    Morgan CM; Hadley ME
    Neuroendocrinology; 1976; 21(1):10-9. PubMed ID: 1004685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biogenic amines and control of melanophore stimulating hormone release.
    Bower A; Hadley ME; Hruby VJ
    Science; 1974 Apr; 184(4132):70-2. PubMed ID: 4544474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of catecholamines in the control of melanocyte-stimulating hormone secretion in rats.
    Taleisnik S; Tomatis ME; Celis ME
    Neuroendocrinology; 1972; 10(4):235-45. PubMed ID: 4143902
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of chlorpromazine on the secretion of immunoreactive beta-MSH and prolactin in man.
    Plummer NA; Thody AJ; Burton JL; Goolamali SK; Shuster S; Cole EN; Boyns AR
    J Clin Endocrinol Metab; 1975 Aug; 41(2):380-2. PubMed ID: 1159049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanophore stimulating hormone (MSH) release: inhibition by cytochalasin B and "stimulation" by dimethyl sulfoxide.
    Bower SA; Hadley ME
    Endocrinology; 1975 Feb; 96(2):431-9. PubMed ID: 1078655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of alpha-melanocyte-stimulating hormone from dispersed cells of the intermediate lobe of the rat pituitary gland: involvement of catecholamines and adenosine 3',5'-monophosphate.
    Munemura M; Eskay RL; Kebabian JW
    Endocrinology; 1980 Jun; 106(6):1795-803. PubMed ID: 6245851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro study of frog (Rana ridibunda Pallas) neurointermediate lobe secretion by use of a simplified perifusion system. IV. Interaction between dopamine and thyrotropin-releasing hormone on alpha-melanocyte-stimulating hormone secretion.
    Adjeroud S; Tonon MC; Gouteux L; Leneveu E; Lamacz M; Cazin L; Vaudry H
    Gen Comp Endocrinol; 1986 Dec; 64(3):428-34. PubMed ID: 3100385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect and possible mode of action of alpha-melanocyte-stimulating hormone on gonadotropin release in the ovariectomized rat: an in vivo and in vitro analysis.
    Khorram O; DePalatis LR; McCann SM
    Endocrinology; 1984 Jan; 114(1):227-33. PubMed ID: 6418525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of calcium in TRH-induced secretion of alpha-MSH in the frog].
    Lamacz M; Leneveu E; Tonon MC; Bernard C; Gouteux L; Vaudry H
    Ann Endocrinol (Paris); 1986; 47(1):54-6. PubMed ID: 3094425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible aminergic mediation of MSH release and of the CNS effects of MSH and MIF-I.
    Kastin AJ; Schally AV; Kostrzewa RM
    Fed Proc; 1980 Sep; 39(11):2931-6. PubMed ID: 6105977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the interaction between pro-leu-gly-NH2 and catecholaminergic drugs on MSH release from rat pituitaries incubated in vitro.
    Vivas A; Celis ME
    Neuroendocrinology; 1982; 35(3):150-4. PubMed ID: 6127639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the release of melanocyte-stimulating hormone in vitro by rat pituitary glands collected at various times during the oestrous cycle.
    Vivas A; Celis ME
    J Endocrinol; 1978 Jul; 78(1):1-6. PubMed ID: 567239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action potentials in rat and lizard pars intermedia cells: inhibition by dopamine and stimulation by 5-hydroxytryptamine, two suspected regulators of MSH secretion [proceedings].
    Douglas WW; Taraskevich PS
    J Physiol; 1978 Jul; 280():13P. PubMed ID: 690858
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence against mass action direct feedback control of melanophore-stimulating hormone (MSH) release.
    Huntington T; Hadley ME
    Endocrinology; 1974 Aug; 95(2):472-9. PubMed ID: 4546804
    [No Abstract]   [Full Text] [Related]  

  • 15. The hypothalamo-hypophyseal rat explant in vitro: endocrinological studies of the pars intermedia dopaminergic neural input.
    Davis MD
    J Physiol; 1986 Jan; 370():381-93. PubMed ID: 3958980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of apomorphine and ergocriptine on the release of MSH by the pars intermedia of Rana pipiens.
    Smith AF
    Neuroendocrinology; 1975; 19(4):363-76. PubMed ID: 1083962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action potentials in gland cells of rat pituitary pars intermedia: inhibition by dopamine, an inhibitor of MSH secretion.
    Douglas WW; Taraskevich PS
    J Physiol; 1978 Dec; 285():171-84. PubMed ID: 745066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and secretion of proopiomelanocortin peptides from isolated perifused dog pituitary pars intermedia cells.
    Kemppainen RJ; Zerbe CA; Sartin JL
    Endocrinology; 1989 May; 124(5):2208-17. PubMed ID: 2539971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in vivo and in vitro corticotropin-releasing hormone-stimulated release of proopiomelanocortin-derived peptides in cats.
    Willemse T; Mol JA
    Am J Vet Res; 1994 Dec; 55(12):1677-81. PubMed ID: 7887510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal acetylation of melanophore-stimulating hormone in the pars intermedia of Xenopus laevis is a physiologically regulated process.
    Verburg-van Kemenade BM; Jenks BG; Smits RJ
    Neuroendocrinology; 1987 Oct; 46(4):289-96. PubMed ID: 2823159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.